In vitro activity of thiamphenicol against drug-susceptible and drug-resistant strains of Mycoplasma genitalium
Journal of Antimicrobial Chemotherapy · 2025
DOI: 10.1093/jac/dkaf272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Sofie Skovmand und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Artillerivej 5 Copenhagen 2300, Denmark. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Mycoplasma genitalium, Drug Resistance, Bacterial, Thiamphenicol. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Objectives
Mycoplasma genitalium causes a range of urogenital infections. It is inherently resistant to beta-lactam antibiotics, and the first and second-line treatments recommended are azithromycin and moxifloxacin, respectively. However, resistance towards these drugs is rising, and third-line treatment options exhibit cure rates between 40% and 80%. Thiamphenicol, a chloramphenicol analogue, is excreted unchanged in the urine in high concentrations and has previously successfully treated uncomplicated gonorrhoea. This study aimed to test the in vitro activity of thiamphenicol in a collection of M. genitalium strains with various resistance patterns and to exclude antagonism between thiamphenicol and doxycycline.
Methods
Fifty-three strains of M. genitalium were tested for macrolide resistance mutations in the 23S rRNA gene and quinolone resistance-associated mutations in the parC gene. MICs of thiamphenicol, doxycycline, azithromycin, and moxifloxacin were determined using Vero cell cultures followed by quantitative PCR. A chequerboard analysis was performed to exclude antagonism between thiamphenicol and doxycycline in four isolates of M. genitalium.
Results
The thiamphenicol MICs ranged from 1 to 64 mg/L with a median of 8 mg/L, and 94% (n = 50) of the strains had a thiamphenicol MIC ≤ 16 mg/L. Resistance to macrolides, quinolones, and dual-class resistance did not affect the MIC levels of thiamphenicol. The chequerboard analysis excluded antagonism in all four isolates and indicated a synergistic effect in one isolate.
Conclusions
Our study offered encouraging results on the therapeutic potential of thiamphenicol for M. genitalium infections. The possible synergistic relationship between thiamphenicol and doxycycline encourages further studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Artillerivej 5 Copenhagen 2300, Denmark.
- Department of Dermato-Venereology, Bispebjerg University Hospital, Copenhagen, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Sofie Skovmand, Jørgen Skov Jensen
Zitieren
APA
Skovmand, S., Nørgaard, C., Salado-Rasmussen, K., & Jensen, J. S. (2025). In vitro activity of thiamphenicol against drug-susceptible and drug-resistant strains of Mycoplasma genitalium. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf272
Vancouver
Skovmand S, Nørgaard C, Salado-Rasmussen K, Jensen JS. In vitro activity of thiamphenicol against drug-susceptible and drug-resistant strains of Mycoplasma genitalium. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf272
BibTeX
@article{Skovmand2025,
author = {Skovmand, Sofie and Nørgaard, Christina and Salado-Rasmussen, Kirsten and Jensen, Jørgen Skov},
title = {In vitro activity of thiamphenicol against drug-susceptible and drug-resistant strains of Mycoplasma genitalium},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2025},
doi = {10.1093/jac/dkaf272}
}
EUVIMED